Janssen Announces Health Canada Approval Of Cabenuva, First Long-acting Regimen For Treatment Of HIV; Studies Showed Cabenuva Was As Effective As Continuing Daily, Oral, Antiretroviral Regimens In Maintaining Viral Suppression During 48-week Study